New NIH plan outlines HSV research framework with four strategic priorities

In response to the persistent health challenges of herpes simplex virus 1 (HSV-1) and HSV-2, today the National Institutes of Health released the Strategic Plan for Herpes Simplex Virus Research.

Management Board and Supervisory Board of APONTIS PHARMA AG recommend accepting Zentiva’s public tender offer – Biotech Investments

EQS-News: APONTIS PHARMA AG / Key word(s): Tender Offer/Statement Management Board and Supervisory Board of APONTIS PHARMA AG recommend accepting Zentiva’s public tender offer 30.10.2024

October 31, 2024

Think Twice Before Excising Bursa in Shoulder Surgery

Shoulder bursal tissue is often removed during rotator cuff repair, but that might not be such a good idea, researchers said. Studies with human bursa

April 25, 2024

Subasumstat by Takeda Pharmaceutical for Relapsed Multiple Myeloma: Likelihood of Approval

Subasumstat is under clinical development by Takeda Pharmaceutical and currently in Phase II for Relapsed Multiple Myeloma.

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.